Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries

By Edvinsson L.   Sams A.   Jansen-Olesen I.   Tajti J.   Kane S.A.   Rutledge R.Z.   Koblan K.S.   Hill R.G.   Longmore J.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [ 3 H]BIBN4096BS

By Schindler M.   Doods H.N.  

European Journal of Pharmacology, Vol. 442, Iss. 3, 2002-05 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

By Trocóniz Iñaki F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y 1 receptor-selective antagonist [ 3 H]BIBP3226

By Entzeroth M.   Braunger H.   Eberlein W.   Engel W.   Rudolf K.   Wienen W.   Wieland H.A.   Willim K.-D.   Doods H.N.  

European Journal of Pharmacology, Vol. 278, Iss. 3, 1995-05 ,pp. : 239-242

Elsevier

Access to resources Recommend Favorite

Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig

By Kapoor K.   Arulmani U.   Heiligers J.P.C.   Willems E.W.   Doods H.   Villalon C.M.   Saxena P.R.  

European Journal of Pharmacology, Vol. 475, Iss. 1, 2003-08 ,pp. : 69-77

Elsevier

Access to resources Recommend Favorite